[Efficacy and safety of bronchoscopic submucosal polidocanol injection for bronchopleural fistula].

Authors

Y P Gao, J J Wang, M Zheng, H X Fu, Y Wang, Y Z Zhou

Published in

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. Volume 49. Issue 8. Pages 862-865. Aug 12, 2026.

Abstract

A retrospective analysis was conducted of 29 patients with postoperative bronchopleural fistula. All patients had fistulas ≤5 mm in diameter and underwent bronchoscopic submucosal polidocanol injection. The overall treatment efficacy rate was 86.2%. After treatment, Karnofsky Performance Status and dyspnea scores improved significantly compared with pretreatment values (both P<0.05). Post-procedural complications included fever in 3 patients (10.3%), mild hemoptysis in 4 (13.8%), and worsening pneumothorax in 1 (3.4%); no procedure-related infections or deaths occurred. These findings suggest that bronchoscopic submucosal polidocanol injection is an effective and safe treatment for postoperative bronchopleural fistulas ≤5 mm in diameter.

PMID:
42557073
Bibliographic data and abstract were imported from PubMed on 06 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.